login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIOAGE LABS INC (BIOA) Stock News
USA
- NASDAQ:BIOA -
US09077V1008
-
Common Stock
7.49
USD
+0.23 (+3.17%)
Last: 11/10/2025, 8:00:00 PM
7.49
USD
0 (0%)
After Hours:
11/10/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BIOA Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Chartmill
BioAge Labs Inc (NASDAQ:BIOA) Reports Q3 2025 Earnings with Significant Revenue Beat
18 days ago - By: Chartmill
- Mentions:
SLE
AMBI
ITGR
LXEH
...
Here are the top movers in Thursday's session.
4 days ago - By: BioAge Labs, Inc.
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
4 days ago - By: BioAge Labs, Inc.
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
4 days ago - By: BioAge Labs, Inc.
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
4 days ago - By: BioAge Labs, Inc.
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
6 days ago - By: The Motley Fool
- Mentions:
NVO
LLY
C
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy
13 days ago - By: The Motley Fool
- Mentions:
LLY
C
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?
19 days ago - By: Benzinga
- Mentions:
MOH
ITGR
ARMP
RVPH
...
12 Health Care Stocks Moving In Thursday's Intraday Session
19 days ago - By: Chartmill
- Mentions:
CLB
SLE
AMBI
ITGR
...
Which stocks are moving on Thursday?
19 days ago - By: Chartmill
- Mentions:
CLB
SSL
AMBI
ITGR
...
These stocks are gapping in today's session
19 days ago - By: Chartmill
- Mentions:
SLE
MOH
BYND
ARMP
...
Wondering what's happening in today's pre-market session?
19 days ago - By: Benzinga
- Mentions:
CNC
MOH
IBIO
MEDP
...
12 Health Care Stocks Moving In Thursday's Pre-Market Session
a month ago - By: Bragar Eagel & Squire
BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
2 months ago - By: HitGen Inc.
HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor
3 months ago - By: BioAge Labs, Inc.
BioAge Labs to Present at Upcoming Investor Conferences
3 months ago - By: BioAge Labs, Inc.
BioAge Labs to Present at Upcoming Investor Conferences
3 months ago - By: BioAge Labs, Inc.
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
3 months ago - By: BioAge Labs, Inc.
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
3 months ago - By: BioAge Labs, Inc.
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
3 months ago - By: BioAge Labs, Inc.
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
3 months ago - By: Yahoo Finance
BioAge (BIOA) to Analyze Over 17,000 Biobank Samples for Drug Discovery
4 months ago - By: Bragar Eagel & Squire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
5 months ago - By: BioAge Labs, Inc.
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
5 months ago - By: BioAge Labs, Inc.
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
5 months ago - By: BioAge Labs, Inc.
BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
5 months ago - By: BioAge Labs, Inc.
BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank
5 months ago - By: BioAge Labs, Inc.
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
5 months ago - By: BioAge Labs, Inc.
BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates
6 months ago - By: Yahoo Finance
- Mentions:
TRVI
SPT
VRT
LLY
...
H.C. Wainwright Initiates Coverage of Trevi Therapeutics (TRVI) With Buy Rating
6 months ago - By: BioAge Labs, Inc.
BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
6 months ago - By: BioAge Labs, Inc.
BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
6 months ago - By: BioAge Labs, Inc.
BioAge Labs to Present at Upcoming Investor Conferences
6 months ago - By: BioAge Labs, Inc.
BioAge Labs to Present at Upcoming Investor Conferences
6 months ago - By: Bragar Eagel & Squire
BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
6 months ago - By: BioAge Labs, Inc.
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
6 months ago - By: BioAge Labs, Inc.
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
Please enable JavaScript to continue using this application.